एली लिली एंड कंपनी

एली लिली एंड कंपनी के बारे में

Eli Lilly and Company is a global pharmaceutical company engaged in the research, development, and commercialization of human medicines. Its portfolio spans diabetes care, with insulin products such as Basaglar, Humalog, Humulin, and insulin lispro, as well as type 2 diabetes therapies including Jardiance, Trajenta, and Trulicity. The company also develops and markets treatments in areas such as oncology, immunology, and neuroscience.

यह क्यों महत्वपूर्ण है

As one of the largest publicly traded pharmaceutical companies by market capitalization, Eli Lilly is closely watched for its role in diabetes and metabolic disease treatment, where it competes with other major drugmakers. Its broad product portfolio and pipeline of investigational medicines make it a key constituent of the healthcare sector and major stock indices. Investors and traders monitor the company's clinical trial results, regulatory decisions, and product launches, which can influence its business outlook and sector sentiment.

हम LLY पर कैसे शोध करते हैं

उपरोक्त जैसी मूलभूत बातें हमारे मूलभूत स्क्रीन — EPS त्वरण, ROE और गति∧गुणवत्ता — एकमात्र शोध वर्ग जो हमारे परीक्षण में वॉक-फॉरवर्ड से बचता है। हम मूल्य लक्ष्य या खरीद/बिक्री कॉल जारी नहीं करते: देखें /एज कितनी कठोरता से (और कितनी शायद ही कभी) कुछ भी पास होता है। यह पृष्ठ बाजार डेटा और शोध है, निवेश सलाह नहीं.